Multiple Sclerosis Predictions and Sensitivity Analysis Using Robust Models
Alex Kibet*, Gilbert Langat
Journal of Intelligent Medicine and Healthcare, Vol.3, pp. 1-14, 2025, DOI:10.32604/jimh.2022.062824
- 04 April 2025
Abstract Multiple Sclerosis (MS) is a disease that disrupts the flow of information within the brain. It affects approximately 1 million people in the US. And remains incurable. MS treatments can cause side effects and impact the quality of life and even survival rates. Based on existing research studies, we investigate the risks and benefits of three treatment options based on methylprednisolone (a corticosteroid hormone medication) prescribed in (1) high-dose, (2) low-dose, or (3) no treatment. The study currently prescribes one treatment to all patients as it has been proven to be the most effective on More >